Common use of Pricing Information Provided Orally by Underwriters Clause in Contracts

Pricing Information Provided Orally by Underwriters. [set out key information included in script that will be used by underwriters to confirm sales] Schedule 4-A ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Issuer: Principal Amount: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ ] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Schedule 4-B ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Issuer: Size: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ ] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Annex B-1 Form of Opinion of Freshfields Bruckhaus Xxxxxxxx US LLP (-) The Company is validly existing as a corporation in good standing under the laws of the State of Delaware and is duly qualified to do business as a foreign corporation and is in good standing in the State of California, and the Company has corporate power and authority to own its properties, conduct its business as described in the Disclosure Package and the Prospectus, issue the Securities, enter into the Underwriting Agreement and perform its obligations thereunder.

Pricing Information Provided Orally by Underwriters. Initial Public Offering Price Annex A-1 Annex B X.X. Xxxxxx Securities LLC Xxxxx Xxxxxxx & Co. Xxxxx and Company, LLC Xxxxxx X. Xxxxx & Co. Oxford Immunotec Global PLC [set out key information included in script that will be used by underwriters to confirm sales•] Schedule 4-A ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Ordinary Shares Issuer: Principal AmountOxford Immunotec Global PLC NASDAQ Symbol: MaturityOXFD Shares offered: Coupon: [•] (excluding option to purchase up to [•] additional ordinary shares) Price to Publicpublic: $ [•] per share Net proceeds: $ [•] (excluding option to purchase up to [•] additional ordinary shares) Closing date: [Proceeds (Before Expenses) to Issuer•]: [, 2013 Use of Proceeds]: Interest Payment Approximately $25.0 million to hire additional sales, marketing and Reset Datescustomer service personnel and expand marketing programs both in the United States and outside the United States; approximately $11.0 million to fund research and development programs dedicated to development of new diagnostic tests in the field of immunology; approximately $6.0 million to repay indebtedness outstanding under the Issuer’s senior secured term debt facility and related accrued interest; and approximately $21.8 million for working capital and other general corporate purposes. CUSIP/ISIN: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. G6855A 103/GB00BGFBB958 The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send to you the prospectus and prospectus supplement if you request it by calling 1toll-8[ ]free X.X. Xxxxxx Securities LLC, c/o Broadridge Financial Solutions at 0-[ ] or by e000-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Schedule 4000-B ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Issuer: Size: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ ] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx0000. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Annex B-1 Form of Opinion of Freshfields Bruckhaus Xxxxxxxx US LLP (C Written Testing-) The Company is validly existing as a corporation in good standing under the laws of the State of Delaware and is duly qualified to do business as a foreign corporation and is in good standing in the State of California, and the Company has corporate power and authority to own its properties, conduct its business as described in the Disclosure Package and the Prospectus, issue the Securities, enter into the Underwriting Agreement and perform its obligations thereunder.the-Waters Communications

Pricing Information Provided Orally by Underwriters. [set out key information included in script that will be used by underwriters to confirm sales] Schedule 4-A ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•20[·] Issuer: Principal Amount: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ ] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Schedule 4-B ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Issuer: Size: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ ] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Schedule 4-B ORACLE CORPORATION Pricing Term Sheet for Notes due 20[·] Issuer: Size: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: Underwriters: The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ ] or by e-mailing Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Annex B-1 Form of Opinion of Freshfields Bruckhaus Xxxxx Xxxx & Xxxxxxxx US LLP (-) The Company is validly existing as a corporation in good standing under the laws of the State of Delaware and is duly qualified to do business as a foreign corporation and is in good standing in the State of California, and the Company has corporate power and authority to own its properties, conduct its business as described in the Disclosure Package and the Prospectus, issue the Securities, enter into the Underwriting Agreement and perform its obligations thereunder.

Pricing Information Provided Orally by Underwriters. [set out key information included in script that will be used by underwriters to confirm sales] Schedule 4-A ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Issuer: Principal Amount: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ 8[•]-[•] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg Xxxxxxxxx or another email system. Schedule 4-B ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Issuer: Size: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ 8[•]-[•] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg Xxxxxxxxx or another email system. Annex B-1 Form of Opinion of Freshfields Bruckhaus Xxxxxxxx US LLP (-) The Company is validly existing as a corporation in good standing under the laws of the State of Delaware and is duly qualified to do business as a foreign corporation and is in good standing in the State of California, and the Company has corporate power and authority to own its properties, conduct its business as described in the Disclosure Package and the Prospectus, issue the Securities, enter into the Underwriting Agreement and perform its obligations thereunder.

Pricing Information Provided Orally by Underwriters. [set out key information included in script that will be used by underwriters to confirm sales] Schedule 4-A ORACLE CORPORATION 4 CNOOC LIMITED Pricing Term Sheet for Notes due 20[•] 20 % Notes due 20 (the “20 Notes”) Issuer: Guarantor: Principal Amount: Maturity Date: Coupon (Interest Rate): Public Offering Price: Ranking: Format: Listing: Denomination: Yield to Maturity: CouponSpread to Benchmark Treasury: Benchmark Treasury: Benchmark Treasury Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]and Yield: Interest Payment and Reset Dates: Day Count ConventionInterest Payment Record Dates: [Redemption Provisions]Optional Redemption: Trade Date: Settlement Date: Denominations CUSIP/ISIN: Ratings*: Joint Lead Managers and Joint Bookrunners: Co-Managers: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision revised or withdrawal withdrawn at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ ] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and Each rating should be disregarded. Such disclaimer or notice was automatically generated as a result evaluated independently of this communication being sent by Bloomberg or another email system. Schedule 4-B ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Issuer: Size: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any timeother rating. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you copies of the prospectus supplement and the accompanying prospectus supplement if you request it by calling 1-8[ may be obtained from , [address]-[ ] , telephone: ; , [address], telephone: ; or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx, [address], telephone: . Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Annex B-1 B Form of Opinion of Freshfields Bruckhaus Xxxxx Xxxx & Xxxxxxxx US LLP (-) The Company is validly existing as a corporation in good standing under the laws of the State of Delaware and is duly qualified to do business as a foreign corporation and is in good standing in the State of California, and the Company has corporate power and authority to own its properties, conduct its business as described in the Disclosure Package and the Prospectus, issue the Securities, enter into the Underwriting Agreement and perform its obligations thereunder.LLP

Pricing Information Provided Orally by Underwriters. [set out key information included in script that will be used by underwriters to confirm sales] Schedule 4-A ORACLE CORPORATION ADOBE SYSTEMS INCORPORATED Pricing Term Sheet for Notes due 20[•20[·] Issuer: Principal Amount: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: Trade Date: Settlement Date: Denominations Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ ] or by e-mailing Oracle Corporation’s Investor Relations at xxxxxxxx_xx@xxxxxx.xxx. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Schedule 4-B ORACLE CORPORATION Pricing Term Sheet for Notes due 20[•] Issuer: Size: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to IssuerBenchmark Treasury]: [Use of Proceeds]: Interest Payment Spread from Benchmark Treasury] [Yield to Maturity] [Benchmark Treasury Price and Reset Dates: Day Count Convention: [Redemption ProvisionsYield]: Trade Date: Settlement Date: Denominations Denominations: Ratings: * Underwriters: * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[ ]-[ [·] [·] or by e-mailing Oracle Corporation’s calling Investor Relations [·]. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Schedule 4-B ADOBE SYSTEMS INCORPORATED Pricing Term Sheet for Notes due 20[·] Issuer: Principal Amount: Maturity: Coupon: Price to Public: [Proceeds (Before Expenses) to Issuer]: [Use of Proceeds]: Interest Payment and Reset Dates: Day Count Convention: [Redemption Provisions]: [Benchmark Treasury]: [Spread from Benchmark Treasury] [Yield to Maturity] [Benchmark Treasury Price and Yield]: Trade Date: Settlement Date: Denominations: Ratings: Underwriters: Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at xxxxxxxx_xx@xxxxxx.xxxany time. The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling 1-8[·] [·] or by calling Investor Relations [·]. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. Annex B-1 [Form of Opinion of Freshfields Bruckhaus Xxxxxx Xxxxxxx Xxxxxxxx US LLP (-) The Company is validly existing as a corporation in good standing under the laws of the State of Delaware and is duly qualified to do business as a foreign corporation and is in good standing in the State of California, and the Company has corporate power and authority to own its properties, conduct its business as described in the Disclosure Package and the Prospectus, issue the Securities, enter into the Underwriting Agreement and perform its obligations thereunder.& Xxxxxx]